Publication | Open Access
Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules
23
Citations
0
References
2014
Year
MedicineMelanomaImmune Checkpoint InhibitorDermatologyCancer TreatmentOncologyRadiation OncologyAdvanced MelanomaSkin Cancer
No additional data available for this publication yet. Check back later!